Table 2 Patient characteristics of sub-group of Group-A: baseline (Month 0) and end of observation (Month 12).
Sub-group (n) | A1 (n=11) | A2 (n=14) | A1 vs. A2 (M0) | ||||
|---|---|---|---|---|---|---|---|
Period | Month 0 | Month 12 | P-value | M0 | M12 | P-value | P-value |
NRS on HD day | 6.36±1.12 | 4.54±2.54 | 0.024 | 4.92±1.14 | 2.78±2.19 | 0.002 | 0.004 |
NRS on HD-free day | 5.45±1.19 | 2.81±2.78 | 0.040 | 1.71±0.99 | 1.21±2.04 | 0.265 | 0.000 |
Age (yo) | 75±11 | 72±13 | 0.522 | ||||
Male (%) | 4 (36.4%) | 11 (78.6%) | 0.057 | ||||
HD vintage (days) | 4067±2316 | 2951±1218 | 0.168 | ||||
Presence of DM (%) | 4 (36.4%) | 6 (42.9%) | 0.887 | ||||
Past history of CVD (%) | 5 (45.5%) | 5 (35.7%) | 0.347 | ||||
BMI | 22.1±4.3 | 21.9±2.4 | 0.904 | ||||
DW (kg) | 54.7±15.7 | 55.2±15.0 | 0.470 | 62.8±10.0 | 61.3±11.0 | 0.072 | 0.137 |
Fat mass (kg) | 16.3±10.8 | 17.9±8.1 | 0.284 | 17.6±6.4 | 13.8±5.5 | 0.048 | 0.925 |
Skeletal muscle mass (kg) | 16.4±5.1 | 15.6±5.5 | 0.238 | 21.2±4.0 | 22.9±4.3 | 0.029 | 0.027 |
ECV/TBW (%) | 49.1±4.4 | 50.3±4.7 | 0.110 | 49.3±4.0 | 47.2±3.3 | 0.017 | 0.144 |
Pre HD MBP (mmHg) | 104±19 | 100±7 | 0.649 | 100±11 | 101±17 | 0.865 | 0.524 |
Post HD MBP (mmHg) | 96±14 | 98±14 | 0.817 | 101±14 | 99±14 | 0.571 | 0.422 |
MMSE (arbitrary) | 27±4 | 27±4 | 0.680 | 27±3 | 27±4 | 0.523 | 0.725 |
